ArticleACS nano2013

Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo.

Huan Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.